Tally Health teams up with Pvolve and Cenegenics

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Consumer longevity company partners with wellness firms to advance personalized, preventive solutions for healthy aging.

Consumer longevity biotech Tally Health has announced two new partnerships focused on advancing personalized approaches to managing aging. The strategic collaborations – with performance health company Cenegenics and functional fitness brand Pvolve – seek to integrate Tally’s epigenetic science with lifestyle-based wellness strategies to drive healthspan improvements.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Danny Sullivan

Danny has worked in technology communications for more than 20 years, and has been writing about developments the longevity sector since 2019. With a keen interest in the transfer of technology to market, he focuses primarily on the companies working on cutting-edge solutions to aging and age-related diseases.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oyster surfaces with $60m and a tau degrader that travels light

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE